the Remineralizing Self-Assembling Peptide P11-4, 2% Arginine Enriched Sodium Fluoride and Functionalized Tri Calcium Phosphate Fluoride White Spot Lesions
NCT ID: NCT05127889
Last Updated: 2021-11-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
39 participants
INTERVENTIONAL
2022-01-01
2024-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A) Primary Objective
Assessment of:
* Dimensions of the WSLs through digital photography.
* The color of WSLs through spectrophotometer. B) Secondary Objectives
Assessment of:
• Degree of remineralization using Polarized Light Microscope.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A) Primary Objective
Assessment of:
* Dimensions of the WSLs through digital photography.
* The color of WSLs through spectrophotometer. B) Secondary Objectives
Assessment of:
• Degree of remineralization using Polarized Light Microscope.
PICOTS:
• P - Participants: Children in the age group of 8-12 years having early demineralized carious lesions (WSLs).
* I - Intervention: -Self-assembling peptide P11-4 varnish
* Arginine enriched Sodium Fluoride varnish C- Comparison:- Functionalized Tri Calcium Phosphate Fluoride varnish
* O -Outcomes:- Reduction in WSLs dimensions and color improvement.
* Reduction in degree of demineralization of WSLs.
* T- Time: study period will be over 9 months.
* S- Study design: Randomized Controlled Trial (RCT) and in vitro study
This study will consist of two parts: in vivo part (RCT) and in vitro part:
1. In vivo part:
• Study design: Randomized controlled trial (RCT)
• Grouping:
Patients will be randomly allocated into one of the three groups (13/each):
Group 1: Self-assembling peptide P11-4 varnish (study group) Group 2: Arginine-enriched Sodium Fluoride varnish (study group) Group 3: Tri Calcium Phosphate Fluoride varnish (positive control group)
Materials used in the study:
• Self-assembling-peptide (P11-4)
* Fluoride varnish with TCP5%
* L-Arginine Sodium Fluoride Varnish
* Clinical procedures:
All interventions will be performed by the primary investigator as follows:
• The dental plaque deposit has to be removed before the assessment. Dental prophylaxis will be performed with a bristle brush and non-fluoridated prophylactic paste during the initial clinical examination and before any examination.
* photographic assessment by digital camera and color change( E) readings by digital spectrophotometer ( VITA Easy shade) will be performed at 0 , 3 months, 6 months and 9 months throughout the study period for all the patients.
* During the photographic assessment, all the photographs will be taken with digital camera, Macro lens configuration will be used, the image quality will be set as fine and ISO sensitivity 200. All images will be saved as Joint Photographic Experts Group (JPEG) files suitable for manipulation with the image analysis software.
* Patient's confidentiality will be respected through the photographic technique.
* After digital images captured, they will be downloaded and stored as JPEG. Then the images will be analyzed, and compared with baseline images by Abode Photoshop and Auto CAD
* The enamel color of each WSL will be measured using the spectrophotometer.
* All measurements will be performed under standardized ambient conditions to ensure accuracy and reproducibility.
* Three images will be randomly captured for each lesion and analyzed.
Group 1 (Self assembling peptide P11-4) Prior to application of the test material the following will be done:
• Test lesions will be wiped with NaOCl to remove pellicle,
* Etched for 20 s with 35% H3PO4 Etching Gel to remove mineral deposits on the tooth surface and rinsed with water in accordance with the manufacturer's instructions.
* The lesions will be dried and isolated with cotton rolls.
* The varnish will be applied and left undisturbed for 5minutes (till disappearance) to allow diffusion of self-assembly.
Group 2 (Arginine Enriched Sodium fluoride group) Preparation and application of the varnish as following:
• The Arginine powder will be suspended at 2%.
• A 10 mL of 5% sodium fluoride varnish tube dispensed in a sterile container.
• 200 mg of Arginine will be vigorously mixed with the varnish matrix for 60 sec using a sterile microbrush.
• After dryness of the white spot lesion, the prepared varnish will be applied evenly using the micro brush.
• After application the patient will be instructed to avoid rinsing, eating soft diet and avoid hot drinks for 2 hrs.
Group 3 (Tri Calcium Phosphate fluoride) the material will be applied according to the manufacturing instructions as following:
* To limit undesirable oral ingestion, the appropriate dose for the patient will be determined with the help of the dosing guide.
* The varnish will be mixed with the brush to avoid separation of the material during storage
* However, to guarantee the best results suction will be used during application of the varnish.
* A thin uniform layer of the varnish will be applied on the lesion surface by using the supplied brush
* The applicator brush won't be moved through accumulated saliva to prevent premature setting on the bristles.
* After application the patient will be instructed to close his mouth, avoid rinsing, eating soft diet and avoid hot drinks for 4 hrs.
All patients will be encouraged to maintain good oral hygiene through regular brushing.
Follow up
Patients will be recalled for further applications after 3 and 6 months (20) and for WSLs assessment after 3, 6, 9 months.
Outcome measurement:
Photographic assessment and color change reading outcomes will be assessed by two other blinded calibrated examiners at the following periods:
1\. Baseline 2. 3-month evaluation 3. 6-month evaluation 4. 9-month evaluation
Photographic assessment:
The following will be determined, from photographs for all the patients in relation to WSLs:
1. The area of the labial surface of the tooth
2. WSL area
3. The area of WSL to area of the labial surface of the tooth ratio percent (Percent of WSL)
4. The percentage of WSL ratio related to initial condition at the measured time (Relative Percent)
5. The percentage of decrease in WSL ratio due to time (Percent Decrease)
6. The decrease in the WSL area related to the initial condition (Relative Decrease) Color change readings
* The values of L\* (differences in lightness munsell system ranging from O (black) to 100 (white)), a\* (green-red coordinate), and b\* (blue yellow coordinate) will be recorded for the WSL and the adjacent sound enamel.
* Color change, will be calculated as the color difference between the treated and untreated enamel.
* Participant timeline The study interventions are expected to be conducted from 2021 until 2023.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Self-assembling peptide P11-4 varnish (study group)
* Test lesions will be wiped with NaOCl to remove pellicle,
* Etched for 20 s with 35% H3PO4 Etching Gel to remove mineral deposits on the tooth surface and rinsed with water in accordance with the manufacturer's instructions.
* The lesions will be dried and isolated with cotton rolls.
* The varnish will be applied and left undisturbed for 5minutes (till disappearance) to allow diffusion of self-assembly.
curodont
* To limit undesirable oral ingestion, the appropriate dose for the patient will be determined with the help of the dosing guide.
* The varnish will be mixed with the brush to avoid separation of the material during storage
* However, to guarantee the best results suction will be used during application of the varnish.
* A thin uniform layer of the varnish will be applied on the lesion surface by using the supplied brush
* The applicator brush won't be moved through accumulated saliva to prevent premature setting on the bristles.
* After application the patient will be instructed to close his mouth, avoid rinsing, eating soft diet and avoid hot drinks for 4 hrs.
Arginine-enriched Sodium Fluoride varnish (study group)
* The Arginine powder will be suspended at 2%.
* A 10 mL of 5% sodium fluoride varnish tube dispensed in a sterile container.
* 200 mg of Arginine will be vigorously mixed with the varnish matrix for 60 sec using a sterile microbrush.
* After dryness of the white spot lesion, the prepared varnish will be applied evenly using the micro brush.
* After application the patient will be instructed to avoid rinsing, eating soft diet and avoid hot drinks for 2 hrs.
curodont
* To limit undesirable oral ingestion, the appropriate dose for the patient will be determined with the help of the dosing guide.
* The varnish will be mixed with the brush to avoid separation of the material during storage
* However, to guarantee the best results suction will be used during application of the varnish.
* A thin uniform layer of the varnish will be applied on the lesion surface by using the supplied brush
* The applicator brush won't be moved through accumulated saliva to prevent premature setting on the bristles.
* After application the patient will be instructed to close his mouth, avoid rinsing, eating soft diet and avoid hot drinks for 4 hrs.
Tri Calcium Phosphate Fluoride varnish (positive control group)
* To limit undesirable oral ingestion, the appropriate dose for the patient will be determined with the help of the dosing guide.
* The varnish will be mixed with the brush to avoid separation of the material during storage
* However, to guarantee the best results suction will be used during application of the varnish.
* A thin uniform layer of the varnish will be applied on the lesion surface by using the supplied brush
* The applicator brush won't be moved through accumulated saliva to prevent premature setting on the bristles.
* After application the patient will be instructed to close his mouth, avoid rinsing, eating soft diet and avoid hot drinks for 4 hrs.
All patients will be encouraged to maintain good oral hygiene through regular brushing.
curodont
* To limit undesirable oral ingestion, the appropriate dose for the patient will be determined with the help of the dosing guide.
* The varnish will be mixed with the brush to avoid separation of the material during storage
* However, to guarantee the best results suction will be used during application of the varnish.
* A thin uniform layer of the varnish will be applied on the lesion surface by using the supplied brush
* The applicator brush won't be moved through accumulated saliva to prevent premature setting on the bristles.
* After application the patient will be instructed to close his mouth, avoid rinsing, eating soft diet and avoid hot drinks for 4 hrs.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
curodont
* To limit undesirable oral ingestion, the appropriate dose for the patient will be determined with the help of the dosing guide.
* The varnish will be mixed with the brush to avoid separation of the material during storage
* However, to guarantee the best results suction will be used during application of the varnish.
* A thin uniform layer of the varnish will be applied on the lesion surface by using the supplied brush
* The applicator brush won't be moved through accumulated saliva to prevent premature setting on the bristles.
* After application the patient will be instructed to close his mouth, avoid rinsing, eating soft diet and avoid hot drinks for 4 hrs.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who are medically free from any diseases that would cause enamel defects.
* Patients should have WSLs in labial surface of upper or lower permanent anterior teeth with a score of 1 \& 2 according to the ICDAS that don't require operative intervention.
Exclusion Criteria
* Uncooperative patients
* Mouth breathers
8 Years
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
bardis Sslah
assistant lecturer
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PED21-3D
Identifier Type: -
Identifier Source: org_study_id